The Invention Lab, an early investment institution and TIPS operator, announced on the 20th that it had made concentrated investments in five promising startups in the bio and healthcare fields. This investment, with a total scale of 1 billion won, was conducted in startups with cutting-edge technologies such as robotic surgical assistance, digital pathology, and biomaterial development, and was made in conjunction with The Invention Lab’s open innovation program and strategic fund.
The companies being invested in include: △H-Medic Gear (CEO Hwang Hee-sun), which develops laparoscopic surgery assistance robot solutions; △The K Company (CEO Kim Seong-woo), which develops IT solutions for digital transformation in the cosmetics clinical field; △Urban Data Lab (CEO Ahn Chi-seong), which develops digital pathology and AI-based cancer diagnosis assistance solutions; △Dermare (CEO Han Ji-seong), which develops high-purity vegan PDRN (Polydeoxyribonucleotide) based on seaweed; and △Carbon & Nature (CEO Shin Hyeon-yong), an eco-friendly technology company that recycles oyster shells based on carbon capture and conversion technology.
Director Min-soo Kim, who oversees the investment team at The Invention Lab, said, “Through this investment, we plan to actively support startups that will lead innovation in the bio and healthcare fields to grow rapidly,” adding, “In particular, we will continue to make strategic investments and expand our network, focusing on companies with high potential for entering the global market.”
- See more related articles
You must be logged in to post a comment.